RecruitingNCT05325736
Improvement in Glycemic Response After Bariatric Surgery
Sponsor
Weizmann Institute of Science
Enrollment
120 participants
Start Date
Jul 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
decipher the role of microbiota in glycemic response change after bariatric surgery
Eligibility
Min Age: 18 YearsMax Age: 70 Years
Inclusion Criteria3
- candidates of bariatric surgery or cholecystectomy
- age 18-70
- male/female
Exclusion Criteria7
- previous bariatric surgery
- type 1 diabetes
- antibiotic treatment 3 months prior to the study
- probiotic treatment 3 months prior to the study
- chronic disease - gastrointestinal disease, malignancy, psychiatric disorder, endocrinologic disorders
- any pathologic findings during endoscopy
- participants who will suffer from a post-operation complication
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREsleeve gastrectomy surgery
participants undergoing sleeve gastrectomy surgery
PROCEDUREgastric bypass surgery
participants undergoing gastric bypass surgery
PROCEDUREcontrol
cholecystectomy
PROCEDUREPancreatectomy
Collecting a sample of an unidentified healthy pancreas to extract insulin-secreting beta cells from the sample
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05325736
Related Trials
Recovering From Bariatric Surgery: the Effects of Early Initiated and Supervised Mobilization
NCT062221511 location
Effect of Transcutaneous Electrical Nerve Stimulation on PODD in Bariatric Surgery Patients
NCT075697052 locations
2024 Tirzepatide-Bariatric Surgery
NCT067215071 location
Suzetrigine-enhanced MultimOdal Opioid-sparing THerapy in Cardiac and Bariatric SURGery
NCT075396231 location
Periodontal Microbiota of Patients Candidates for Bariatric Surgery With Body Mass Index Greater Than 30
NCT067812291 location